Publish in this journal
Journal Information
Vol. 10. Issue 3.
Pages 189-190 (May - June 2014)
Vol. 10. Issue 3.
Pages 189-190 (May - June 2014)
Images in Clinical Rheumatology
DOI: 10.1016/j.reumae.2013.12.017
Full text access
Hyperlax Ehlers-Danlos Syndrome: Benign Hypermobility?
Síndrome de Ehlers-Danlos hiperlaxo: ¿hipermovilidad benigna?
Lucía Pantoja Zarzaa,??
Corresponding author

Corresponding author.
, Carolina Díez Morrondoa, Duckens Alexisb
a Unidad de Reumatología, Hospital El Bierzo, Ponferrada, León, Spain
b Servicio de Medicina Interna, Hospital El Bierzo, Ponferrada, León, Spain
Article information
Full Text
Download PDF
Figures (2)
Tables (1)
Table 1. Brighton Criteria for the Diagnosis of Benign Joint Hypermobility Syndrome (1998).
Full Text

Joint hypermobility is the largest amplitude of the normal range of motion of joints, due to increased compliance of the ligaments and joint capsules.1 When joint hypermobility is associated with clinical and/or extra-articular manifestations, the joint hypermobility syndrome (JHMS) or benign joint hypermobility syndrome occurs, defined by the revised Brighton2,3 (Table 1) criteria. Moreover, according to the classification criteria of the Ehlers-Danlos syndrome (EDS) currently employed,4 the former EDS type iii is now classified as hyperlax or hypermobile EDS, and would be virtually identical to the benign joint hypermobility syndrome.2 We report the case of a woman with a hyperlax EDS.

Table 1.

Brighton Criteria for the Diagnosis of Benign Joint Hypermobility Syndrome (1998).

Main criteria 
Four or more points of the Beighton criteria 
Joint pain for longer than 3 months in at least 4 joints 
Minor criteria 
One to 3-points of the Beighton criteria 
Joint pain in one, 2 or 3 joints or back pain or dorsal root pain for more than 3 months 
Dislocation or subluxation of more than one joint, or one joint more than once 
Three or more periarticular lesions (tennis elbow, tenosynovitis, bursitis, etc.) 
Marfanoid habitus (tall, thin, arachnodactyly, etc.) 
Skin abnormalities: striations, hyperextensibility, thin skin, etc. 
Ocular signs myopia or Antimongoloid type 
Varicosities or hernias or uterine or rectal prolapse 

The benign joint hypermobility syndrome is diagnosed if 2 main criteria, or one major and 2 minor, or 4 minor criteria are met. Two minor criteria will suffice if a first degree relative is affected. Major criterion number 1 and minor criteria number 1 and 2 and major criterion 2 and the minor criterion 2 are exclusive.

Clinical Case

The patient is a 27 female graphic designer with a family history that highlights her father with joint hypermobility mainly of the hands, a sister aged 20 and a paternal cousin of the first degree with symptoms of hypermobility, but not studied. She has a history of two pregnancies, an abortion and a healthy 7-year-old daughter, who also has a joint hyperlaxity documented by a Beighton 9/9 hypermobility. From birth the patient showed “extreme” mobility of the joints, which delayed the start of gait and led to repeat sprains since childhood. She frequently performed joint hypermobility maneuvers (Fig. 1). She had bruises and frequent epistaxis. Study of coagulation and platelet function were performed before birth, being normal. Since 3 years prior presents repeating subluxations in the knees and shoulders, so has to travel in a wheelchair for long distances. She presents relapsing tendinopathy of the wrists after holding weight or maintaining positions for writing or drawing, so she cannot practice her profession. Systemic examination was normal. No skin elasticity or transparency was observed, nor was ecchymosis, atopic dermatitis on elbow flexure lesions; Beighton test was 9/9. Passive and active joint mobilities in all joints were explored, over the normal range (Fig. 2), leading to subluxation. The echocardiogram was normal.

Fig. 1.

Joint hypermobility of the lower limbs at 10 years of age.

Fig. 2.

Hyperflexion of the wrist.


Joint hypermobility is less a skill than a problem; there is also a relative confusion in terminology as we stated in the introduction. The EDS includes a group of inherited, rather heterogeneous disorders of connective tissue regarding their clinical and genetic transmission, in which the main finding is, to a greater or lesser extent, vascular, cutaneous, ligamentous and internal organ fragility. The most common types are the classic EDS (by a defect of collagen type v, being a mutation in the COL5A1 and COL5A2 genes in half of the cases), vascular EDS (by a defect in type III collagen, with anomalies in the COL3A1 allele) and hypermobile or hyperlax EDS. But it is increasingly clear that the current classification is inadequate and many patients have overlapping forms of EDS, so they cannot be unambiguously classified into one of5 recognized subtypes 6.

Hypermobile EDS (equivalent to benign joint hypermobility syndrome) is characterized by skin changes (soft, elastic, abnormal scarring), joint pain, myalgia, tendonitis and recurrent subluxations. In children it often delays walking, leads to body contortions (“rubber children’) or ‘juggling acts” with hands.6 No inflammatory signs, laboratory tests or specific radiological signs are found. The precise biochemical alterations and the genetic defects are not well known; there is a family history and it was once considered of autosomal dominant inheritance, but some recent studies indicate that in less than 10% of cases there may be a defect in tensacin gene x, a glycoprotein in the extracellular matrix which is manifested recessively. Its controversial association with mitral valve prolapse, which does not seem to be more prevalent in hypermobile EDS, shows a higher prevalence in a study of patients with hypermobility.2 Its correlation has been demonstrated with chronic fatigue syndrome, fibromyalgia7 anxiety, depression, panic attacks, agoraphobia2,6,8 dysautonomia and osteoporosis in premenopausal women.9

The diagnosis of this syndrome is clinical and confirmed using Brighton criteria.3 Treatment includes preventive measures, rest, physiotherapy and analgesia in the acute phase and then a multidisciplinary rehabilitation approach to restore normal range of joint motion, correct movement dysfunction, improve joint stability, physical condition and mental impact by benign hypermobility. Again adjectives demonstrate how relative they can become.

Ethical ResponsibilitiesProtection of people and animals

The authors declare that no experiments have been performed on humans or animals.

Data confidentiality

The authors declare that they have followed the protocols of their workplace regarding the publication of data from patients and that all patients included in the study have received sufficient information and have given their written informed consent to participate in the study.

Right to privacy and informed consent

The authors have obtained informed consent from patients and/or subjects referred to in the article. This document is in the possession of the corresponding author.

Conflict of Interest

The authors declare no conflicts of interest.

M. Acuso Díaz, E. Collantes Estévez.
La hiperlaxitud articular: ¿síndrome o factor de riesgo?.
Sem Fund Esp Reumatol, 2 (2001), pp. 43-47
R. Grahame, A.J. Hakim.
Curr Opin Rheumatol, 20 (2008), pp. 106-110
R. Grahame, H.A. Bird, A. Child.
The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS).
J Rheumatol, 27 (2000), pp. 1777-1779
P. Beighton, A. de Paepe, B. Steinmann, P. Tsipouras, R.J. Wenstrup.
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997.
Am J Med Genet, 77 (1998), pp. 31-37
B. Callewaert, F. Malfait, B. Loeys, A. de Paepe.
Ehlers-Danlos syndromes and Marfan syndrome.
Best Pract Res Clin Rheumatol, 22 (2008), pp. 165-189
J.F. Bravo.
Ehlers-Danlos syndrome, with special emphasis in the joint hypermobility syndrome.
Rev Med Chile, 137 (2009), pp. 1488-1497
D. Ofluoglu, O.H. Gunduz, E. Kul-Panza, Z. Guven.
Hypermobility in women with fibromyalgia syndrome.
Clin Rheumatol, 25 (2006), pp. 291-293
J. García-Campo, E. Asso, M. Alda.
Joint hypermobility and anxiety: the state of the art.
Curr Psychiatry Rep, 13 (2011), pp. 18-25
S. Gulbahar, E. Sahin, M. Baydar, C. Bircan, R. Kizil, M. Manisali, et al.
Hypermobility syndrome increases the risk for low bone mass.
Clin Rheumatol, 25 (2006), pp. 511-514

Please cite this article as: Pantoja Zarza L, Díez Morrondo C, Alexis D. Síndrome de Ehlers-Danlos hiperlaxo: ¿hipermovilidad benigna? Reumatol Clin. 2014;10:189–190.

Copyright © 2013. Elsevier España, S.L.. All rights reserved
Reumatología Clínica (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.